Additive effect of Lipid-Lowering by atrovaSTatin on Amelioration of Renal hemodynamic in patients with CKD
Not Applicable
Recruiting
- Conditions
- Chronic Kidney Disease(CKD)
- Registration Number
- JPRN-UMIN000006662
- Lead Sponsor
- Departmrnt of CKD initiatives,Nagoya university graduate school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1)Defective diabetic for control(abobe FBS160mg/dL,HbA1c8%) 2)Familial hypercholesteremia. 3)The past of event of cardiovascular disease. 4)High blood pressure that cannot be controlled(above 140mg/dL) 5)Patient who has previous history of hypersensitivity for Atolbastatin or Ezetimibe 6)Woman who has pregnant woman or possibility of pregnancy 7)Patient who judged that it is improper that physician in charge puts it in to examination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method